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Abstract
The effect of the toxic chemical Na-arsenite and the protein synthesis inhibitor anisomycin on glucose transport in primary
cultures of bovine chromaffin cells was compared using the effect of insulin-like growth factor I (IGF-I) as a reference. The
enhanced uptake of glucose obtained in response to arsenite and anisomycin reached maximum after 60 min, with the
response to anisomycin being delayed in onset relative to that of arsenite. At maximal doses the arsenite effect was
consistently higher than that of anisomycin and comparable to theV2-fold effect produced by IGF-I. The selective inhibitor
of stress-activated protein kinase 2 (SAPK2), SB 203580, inhibited completely anisomycin-induced glucose uptake but only
partly suppressed uptake stimulated by arsenite. Both substances, in concentrations producing maximal effects on glucose
transport, led to a strong phosphorylation of SAPK2. In contrast to the effect on glucose transport, the arsenite-induced
phosphorylation of SAPK2 was relatively slow compared to the anisomycin-induced activation. The results indicate that
glucose uptake induced by the two types of cellular stress are mediated by at least two different signaling pathways, which
also differ from that activated by IGF-I. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
One of the early cellular responses to stressful con-
ditions, such as UV irradiation, hypoxia and arsenite
treatment, or to cytokines and pharmacological sub-
stances such as protein synthesis inhibitors, is an in-
crease in the uptake and utilization of glucose [1^3].
Glucose transport is mediated by a family of trans-
porter molecules, GLUT1^7 [4,5], and GLUT1, the
‘housekeeping’ isoform, accounts for basal glucose
transport in most cell types. It has been reported
that cellular stress enhances glucose transport by a
mechanism similar to that of insulin, i.e., transloca-
tion of glucose transporters from an intracellular
compartment to the cell surface [1^3,6^8], while oth-
er studies indicate that changes in the transport rate
are due to alterations in the catalytic activity of in-
dividual transporters [9^13]. The intracellular signal-
transduction pathways involved in stress-induced ac-
tivation of glucose transport are, however, still not
clearly understood.
In recent years it has been realized that responses
to various types of cellular stress are mediated by
signaling pathways leading to activation of stress-ac-
tivated protein kinases (SAPKs), members of the
family of mitogen-activated protein kinases
(MAPK) [14^16]. Although there seems to be a con-
siderable overlap in the signaling responses elicited
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by di¡erent stimuli, the precise quantitative response
of each MAPK subtype appears to be characteristi-
cally linked to the applied stimulating agent [17^19].
The activation of SAPK1 (also named JNK) and
SAPK2 (also named p38) are at the moment the
most studied and best characterized, and recently
the involvement of SAPK2/p38 in anisomycin- and
interleukin 1 (IL-1)-stimulated glucose uptake was
demonstrated in KB cells [20] and in 3T3-L1 adipo-
cytes and Clone 9 cells [13]. However, less is known
about the possible involvement of this or other kin-
ase(s) in glucose transport induced by other types of
cellular stress.
The chroma⁄n cells of the adrenal medulla are
widely used as a model system for studies of sympa-
thetic neurons, and these cells respond to nervous
activation by release of catecholamines and pro-
teins/neuropeptides. It has previously been reported
that exposure to Na-arsenite and osmotic shock
leads to activation of SAPK2/p38 in bovine chromaf-
¢n cells and also increases the activity of tyrosine
hydroxylase, the rate-limiting enzyme in the catechol-
amine synthesis [21]. E¡ects of cellular stress in rela-
tion to uptake of glucose has on the other hand not
been studied in these cells, which mainly rely on glu-
cose for energy supply [22], and in which GLUT1
mediated glucose uptake is doubled in response to
insulin-like growth factor I (IGF-I) [23]. In the
present report we have examined the e¡ect of
Na-arsenite, anisomycin and the cytokines IL-1K
and tumor necrosis factor-K (TNF-K) on glucose
transport in bovine chroma⁄n cells, with emphasis
on comparison of the e¡ects of arsenite and aniso-
mycin. The potential signaling pathways involved in
the stress-induced glucose uptake were examined us-
ing speci¢c inhibitors of phosphatidylinositol (PI) 3-
kinase, p70 ribosomal S6 kinase (p70S6 kinase),
MAPK kinase 1 (MEK1) and SAPK2/p38. Activa-
tion of SAPKs was studied by the use of speci¢c
antibodies against the phosphorylated form of the
enzymes.
2. Materials and methods
2.1. Materials
Collagenase type I, DNAse type 1, 2-deoxy-D-glu-
cose, cytochalasin B, wortmannin, rapamycin and
anisomycin were obtained from Sigma, St. Louis,
MO, USA. Dulbecco’s modi¢ed Eagle’s medium
(DMEM), Ham’s nutrient F12 medium (F12), new-
born calf serum (NBCS) and antibiotics were from
Gibco BRL, Paisley, UK. 2-[3H]Deoxyglucose (spe-
ci¢c activity 30.6 Ci/mmol) was purchased from
Amersham Int., Buckinghamshire, UK. Urogra¢n-
60 was obtained from Schering, Berlin, Germany.
Recombinant human IGF-I was from Peninsula
Laboratories, Merseyside, UK and recombinant hu-
man TNF-K and IL-1K were from RpD systems,
Abingdon, UK. LY 294002 was purchased from Bio-
mol, Plymouth Meeting, PA, USA. Phospho- and
nonphospho-SAPK1/JNK and SAPK2/p38 antibod-
ies, horseradish peroxidase-conjugated secondary
antibodies and chemiluminescent detection reagents
were obtained from New England Biolabs, Beverly,
MA, USA. Reagents for electrophoresis, protein as-
say and high molecular mass standard were obtained
from Bio-Rad Laboratories, Richmond, CA, USA.
Hybond ECL nitrocellulose membrane and Hyper-
¢lm MP were from Amersham. Plasticware for cell
culture was purchased from NUNC, Roskilde, Den-
mark. SB 203580 and PD 98059 were a gift from
Dr. Philip Cohen (University of Dundee, Dundee,
UK).
2.2. Isolation and culture of chroma⁄n cells
Chroma⁄n cells were isolated from bovine adrenal
medullae as previously described [23] and puri¢ed by
centrifugation on a Urogra¢n gradient [24]. The cells
were further puri¢ed by di¡erential plating to a pu-
rity of 90^95% and seeded at a ¢nal density of
5U105 cells/cm2 in DMEM/F12 (1:1) supplemented
with 10% NBCS, 100 U/ml penicillin-G, 250 WM as-
corbate, 20 WM 5-£uorodeoxyuridine, 50 U/ml Nys-
tatin, 40 Wg/ml garamycin and 10 WM cytosine ara-
binose. The medium was changed after 2^3 days of
culture and cells were used for experiments on day
5 or 6.
2.3. Glucose transport assay
Transport was determined by measuring the up-
take of 2-[3H]deoxyglucose as described in [23]. The
cells were kept in serum-free DMEM/F12 for mini-
BBAMCR 14568 26-11-99
C. Fladeby, G. Serck-Hanssen / Biochimica et Biophysica Acta 1452 (1999) 313^321314
mum 4 h prior to incubations with inhibitors/ago-
nists as indicated, then rinsed twice with KRP
(10 mM Na phosphate bu¡er, 129 mM NaCl, 5.1
mM KCl, 1.3 mM MgSO4, 1 mM CaCl2, pH 7.4).
Glucose uptake was measured at room temperature
and was initiated by addition of KRP, containing
0.5 mM 2-deoxyglucose and 0.5 WCi 3H-labeled
2-deoxyglucose/ml, and terminated after 3 min by
adding ice-cold KRP containing 20 WM cytochalasin
B. The cells were rinsed three times with ice-cold
PBS, solubilized in 0.2 M NaOH, neutralized with
concentrated HCl, and aliquots were taken for scin-
tillation counting and protein determination. Values
were corrected for nonspeci¢c uptake by subtracting
uptake in presence of cytochalasin B. Protein was
determined using the Bio-Rad microassay system
with bovine serum albumin as standard.
2.4. Cell lysis and immunoblotting
Cells seeded in 6-well plates were preincubated in
serum-free DMEM/F12 for a minimum of 4 h before
exposure to the di¡erent compounds as indicated.
The cells were washed in PBS and lysed by adding
100 Wl of SDS Sample Bu¡er (62.5 mM Tris^HCl
(pH 6.8), 2% SDS, 10% glycerol, 50 mM dithiothrei-
tol, 0.1% bromophenol blue) to each well and imme-
diately scraped o¡ the plate and kept on ice. The
samples were sonicated for 10 s and heated to 95^
100‡C for 5 min. The samples were run on 10%
SDS^PAGE gels, 20 Wl/lane, and blotted to nitrocel-
lulose membranes in a horizontal semidry system
(Pharmacia, Sweden). The membranes were washed
and incubated with phospho- and nonphosphospe-
ci¢c SAPK2/p38 antibodies according to the protocol
supplied by the producer. The proteins were detected
by incubating the membrane for 1 min with Lumi-
GLO chemiluminescent reagent and exposure to Hy-
per¢lm. The membranes were stripped in 100 mM
L-mercaptoethanol, 2% SDS, 62.5 mM Tris^HCl
(pH 6.8) at 60‡C for 30 min and each membrane
was reprobed with the di¡erent antibodies.
2.5. Statistical analysis
Statistical evaluation of data from two groups was
done by unpaired Student’s t-test and when more
than two groups were compared, two-way analysis
of variance followed by Tukey test for multiple com-
parisons was used.
3. Results
3.1. Stress-induced increase in glucose transport in
chroma⁄n cells
The basal uptake of 2-deoxyglucose in chroma⁄n
cells was in the present experiments estimated to
1.1 þ 0.2 nmol/mg protein per min, a value in good
agreement with our previously published data [23].
Treating the cells with both Na-arsenite and aniso-
mycin enhanced glucose transport, but as shown in
Fig. 1A the onset of the increased uptake in response
to anisomycin was delayed relative to that of arsen-
ite. The response to anisomycin, on the other hand,
plateaued at a time (60 min) when the response to
arsenite still tended to rise, although at a lower rate
than during the initial 30 min. The time courses for
the responses to both stressors were thus delayed
relative to that of IGF-I, which attained maximum
Table 1
E¡ect of wortmannin on enhanced glucose transport in re-
sponse to arsenite, anisomycin and IGF-I
No inhibitor 100 nM Wortmannin
Basal 1.0 0.68 þ 0.05
Arsenite 2.13 þ 0.13a 1.57 þ 0.10b
Anisomycin 1.66 þ 0.07a 1.24 þ 0.03b
IGF-I 1.84 þ 0.10a 0.72 þ 0.04d
Arsenite+IGF-I 2.75 þ 0.28a;c 1.65 þ 0.14b;d
Anisomycin+IGF-I 2.44 þ 0.28a;c 1.21 þ 0.14b;d
Chroma⁄n cells were preincubated for 30 min in DMEM/F12
in the presence of 100 nM wortmannin or vehicle (DMSO).
The cells were then stimulated for 1 h in the absence (basal) or
presence of 100 WM arsenite, 250 ng/ml anisomycin, or 10 nM
IGF-I, or with arsenite or anisomycin in combination with
IGF-I in the continued absence or presence of inhibitors. Val-
ues, expressed as fold increase in glucose uptake above basal
rate þ S.E.M., are the means of six di¡erent experiments.
a;bSigni¢cant di¡erence (P9 0.02) from basal in the absence
and presence of inhibitor, respectively.
cSigni¢cant di¡erence (P9 0.05) from the uptake stimulated by
IGF-I alone.
dSigni¢cant reduction in uptake from the corresponding re-
sponse in the absence of inhibitor (P9 0.02). There was no sig-
ni¢cant di¡erence between the arsenite and anisomycin response
in the absence and presence of wortmannin, Ps 0.05.
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as early as after 10 min (Fig. 1B). The concentration-
dependent e¡ects of arsenite and anisomycin were
examined after 60 min pretreatment (Fig. 2). The
maximal response to arsenite, obtained at 100 WM,
tended to be higher than the e¡ect obtained with
maximal concentration of IGF-I (10 nM) and was
consistently higher than the V1.6-fold increase pro-
duced by maximal concentration of anisomycin
(250 ng/ml) (Tables 1 and 2). Treating the cells
with either arsenite or anisomycin in combination
with 10 nM IGF-I led to a signi¢cant increase in
glucose uptake compared to the e¡ect of IGF-I
alone, although a complete additive e¡ect was not
obtained (Table 1). The combined treatment with
arsenite and anisomycin did not, on the other
hand, lead to any signi¢cant increase in uptake com-
pared to the e¡ect of arsenite alone (results not
Fig. 2. Concentration-dependent e¡ects of arsenite and aniso-
mycin on uptake of 2-deoxyglucose in chroma⁄n cells. Cells
were exposed to the given concentrations of arsenite (A) and
anisomycin (B) for 1 h prior to analysis of 2-deoxyglucose up-
take. Values, expressed as fold increase above basal rate þ
S.E.M., are the means of three (arsenite) and four (anisomycin)
experiments, each performed with di¡erent cell preparations.
Fig. 1. Time course of arsenite-, anisomycin- and IGF-I-stimu-
lated uptake of 2-deoxyglucose in chroma⁄n cells. Cells were
exposed (A) to 100 WM arsenite (F) and 250 ng/ml anisomycin
(R), and (B) to 10 nM IGF-I, for the indicated time periods.
Uptake of 2-deoxyglucose was measured as described in Section
2. Values, expressed as fold increase in uptake above basal
rate þ S.E.M., are the means of four independent experiments,
each done in duplicate. *P6 0.05, signi¢cantly di¡erent from
values obtained in presence of anisomycin.
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shown). The cytokines TNF-K and IL-1K caused
only small and insigni¢cant e¡ects on glucose uptake
even at concentrations as high as 500 ng/ml and
100 ng/ml, respectively (results not shown).
3.2. Dissection of signaling pathways involved in
stress-induced glucose uptake
Initially a potential role of PI3-kinase in stress-in-
duced uptake was analyzed by means of wortman-
nin, an inhibitor of PI3-kinase. The potency of the
inhibitor was ¢rst established measuring its dose-de-
pendent e¡ect on IGF-I-stimulated transport, which
in various cell lines has been shown to be dependent
on PI3-kinase activation. As illustrated in Fig. 3,
wortmannin inhibited IGF-I-induced glucose trans-
port with an IC50 at V20 nM and complete inhib-
ition was obtained at 100 nM. Basal transport was
reduced by V30% at this concentration. Wortman-
nin had no signi¢cant e¡ect on the enhanced glucose
uptake seen in response to arsenite or anisomycin,
and in cells treated with arsenite or anisomycin in
combination with IGF-I, the observed reduction in
glucose transport in presence of the inhibitor corre-
sponded roughly to the increment in transport activ-
ity obtained by IGF-I alone (Table 1). Preincubation
in the presence of rapamycin, which inhibits the ac-
tivation of p70S6 kinase, had no e¡ect on glucose
transport under the present experimental conditions
(results not shown), indicating that p70S6 kinase has
no function in either stress-induced or in IGF-I-in-
duced uptake of glucose.
We next examined the possible role of SAPK2/p38
in regulation of glucose transport stimulated by ar-
senite and anisomycin. SB 203580, a speci¢c inhibitor
of SAPK2/p38 applied in a concentration of 20 WM
[21], inhibited completely glucose uptake stimulated
by anisomycin, while the arsenite-induced uptake
was reduced only by approximately 30% (Table 2).
This suggested a dependency on SAPK2/p38 activa-
tion for the anisomycin response while the e¡ect of
arsenite appeared to be only partially channeled
through this enzyme. It has been suggested that ar-
senite may exert its e¡ect by interfering with free
thiol groups on proteins like the protein tyrosine
phosphatases [25]. We therefore tested the e¡ect of
the reducing agent dithiothreitol on arsenite-induced
uptake. Stimulating the cells with 100 WM arsenite in
the presence of 2 mM dithiothreitol led to a 1.8-fold
increase in uptake, equivalent to the uptake induced
by arsenite alone. However, dithiothreitol by itself
Table 2
E¡ects of SB 203580 and PD 98059 on arsenite-, anisomycin-
and IGF-I-induced glucose transport
No inhibitor SB 203580 PD 98059
Basal 1.0 0.90 þ 0.10 1.40 þ 0.12a
Arsenite 1.88 þ 0.11a 1.37 þ 0.12b;d 2.07 þ 0.23c
Anisomycin 1.56 þ 0.08a 0.97 þ 0.06d 1.86 þ 0.20c
IGF-I 1.78 þ 0.10a 1.42 þ 0.12b 2.18 þ 0.17c
Cells were preincubated for 1 h in DMEM/F12 in the absence
(vehicle) or presence of SB 203580 (20 WM) or PD 98059
(50 WM) and then for an additional hour in the presence of
100 WM arsenite, 250 ng/ml anisomycin or 10 nM IGF-I. Val-
ues, expressed as fold increase above basal rate þ S.E.M., are
the means of ¢ve di¡erent experiments.
aSigni¢cant di¡erences from basal rate in the absence of inhibi-
tor and
b;csigni¢cant di¡erences from basal rate in the presence of SB
203580 and PD 98059, respectively (P9 0.02).
dSigni¢cant reduction in uptake from the corresponding re-
sponse in the absence of inhibitor, P9 0.02.
Fig. 3. E¡ect of wortmannin on IGF-I-stimulated 2-deoxyglu-
cose uptake. Cells were preincubated for 30 min in presence of
various concentrations of wortmannin prior to addition of
10 nM IGF-I (F) or equal volume of medium (E). The incuba-
tion was continued for an additional hour before uptake of
2-deoxyglucose was measured. The values, presented as
mean þ S.D. of duplicate determinations, are from one represen-
tative experiment. Similar results were obtained in four di¡erent
experiments.
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produced a similar 1.8-fold increase in glucose trans-
port, indicating that the cellular redox state in£uence
the regulation of glucose transport. The fact that
dithiothreitol had the same e¡ect in the presence
and absence of arsenite might suggest that the reduc-
ing agent somehow suppressed the e¡ect of arsenite.
Another possibility may be that each of the com-
pounds exerted a maximal stimulation of glucose
transport via the same pathway, as the combination
of the two did not produce an additive e¡ect on the
transport rate.
We also included studies on the e¡ects of PD
98059, an inhibitor of the MAPK kinase pathway
activated by extracellular mitogens like IGF-I. As
shown in Table 2, PD 98059 had no inhibitory e¡ect
on glucose transport induced by either stimuli. On
the contrary, basal level, as well as glucose transport
stimulated by IGF-I, arsenite and anisomycin, were
elevated in the presence of PD 98059, which rather
suggests a possible inhibitory action of MEK1 or its
downstream cascade(s) on glucose transport in chro-
ma⁄n cells. Recently, it was demonstrated that treat-
ment with PD 98059 resulted in SAPK2/p38 activa-
tion in HeLa cells [26]. In view of this report, the
presently observed e¡ect of PD 98059 on glucose
transport could alternatively be explained by a sim-
ilar activation of SAPK2/p38 by the inhibitor.
3.3. Stress-induced phosphorylation of SAPK1/JNK
and SAPK2/p38
It was of interest to examine the correlation be-
tween arsenite- and anisomycin-induced glucose
transport and SAPK activation. Activation of the
MAPKs is closely related to phosphorylation of the
enzymes [27], and phosphorylation of SAPK2/p38,
and also SAPK1/JNK, in response to arsenite and
anisomycin, TNF-K and IL-1K was therefore studied
by Western immunoblots, using speci¢c antibodies
against the phosphorylated form of the kinases. As
depicted in Fig. 4, SAPK2/p38 was strongly phos-
phorylated in response to anisomycin with maximal
response obtained after 15^30 min, i.e., at a time
considerably earlier than 60 min at which maximal
anisomycin-induced glucose transport was observed.
The time lapse between phosphorylation and trans-
port was thus compatible with a SAPK2/p38 depend-
ent change in glucose transport activity. Exposure to
arsenite also led to phosphorylation of SAPK2/p38
although the e¡ect was somewhat more modest, was
slower in onset and reached maximum after 60 min
of treatment. The phosphorylation of the kinase in
response to arsenite thus appeared delayed relatively
to the initial changes of arsenite-induced glucose up-
take but coincided temporally with maximal trans-
port activity obtained at 60 min. TNF-K, which
was without e¡ect on glucose transport, led to phos-
phorylation of SAPK2/p38. However, the response
was weaker and more transient than that attained
in presence of anisomycin. No phosphorylation of
SAPK2/p38 was evident in the presence of IL-1K
and IGF-I (results not shown). SAPK1/JNK was
strongly phosphorylated in response to anisomycin
while arsenite and TNF-K produced only weak ef-
fects (results not shown). IL-1K and IGF-I did not
induce any phosphorylation of SAPK1/JNK in chro-
ma⁄n cells.
4. Discussion
Multiple, interconnected, phosphorylation cas-
Fig. 4. Arsenite-, anisomycin- and TNF-K-induced phosphorylation of SAPK2/p38. Cells were exposed to arsenite (100 WM), anisomy-
cin (250 ng/ml) and TNF-K (500 ng/ml) for the time indicated. Cells were lysed as described in Section 2, and the lysates were ana-
lyzed by immunoblotting with antibodies to SAPK2/p38 (upper panel) and the phosphorylated form of SAPK2/p38 (lower panel). The
result of a representative experiment is given.
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cades mediate the e¡ects of growth factors and cel-
lular stress on a diversity of cellular functions such as
gene transcription, protein synthesis, and lipid and
glycogen metabolism. Recently the role of these cas-
cades in stress-induced changes in glucose transport,
mediated by the insulin-sensitive GLUT4 and/or the
ubiquitous GLUT1, has been studied in several cell
types [13,20,28]. It is generally assumed that en-
hanced glucose transport can be achieved by altered
intrinsic activity of the transporter itself of by trans-
location to the plasma membrane of transporters
from an intracellular pool. According to the litera-
ture, enhanced glucose transport observed in re-
sponse to anisomycin and arsenite is related to
changes in intrinsic activity and translocation, re-
spectively [1^3,8^10,13].
In this report we have investigated the e¡ects of
anisomycin and arsenite on glucose transport in
chroma⁄n cells, and to our knowledge the present
study is the ¢rst in which the e¡ects of these two
commonly applied stressors on glucose transport
have been studied and compared in the same cell
type. This has allowed us to observe the following
important di¡erences. First, the change in glucose
transport in response to arsenite was stronger and
also faster in onset than that of anisomycin. Second,
SB 203580, a speci¢c inhibitor of SAPK2/p38 com-
pletely attenuated the response to anisomycin but
only partly depressed the arsenite e¡ect. Third, ani-
somycin induced a fast and strong phosphorylation
of SAPK2/p38, with a time course compatible with
the e¡ect on glucose transport, whereas arsenite
caused a more modest phosphorylation of SAPK2/
p38 that was delayed relative to a rapid e¡ect on
glucose transport. These data strongly indicate di¡er-
ences in the signal transduction pathways leading to
increased glucose uptake in response to anisomycin
and arsenite in chroma⁄n cells.
The demonstration that anisomycin-induced glu-
cose transport was dependent on SAPK2/p38 activa-
tion is in agreement with previous reports in human
KB cells [20] and in mouse 3T3-L1 adipocytes and
rat Clone 9 epithelial cells [13]. Although most re-
ports on anisomycin-induced glucose transport indi-
cate a change in the catalytic activity of individual
transporters, the actual mechanism by which
SAPK2/p38 connects to the increase in glucose trans-
port is currently unknown. According to Barros et
al. [13] GLUT1 is predicted to expose intracellular
sites for phosphorylation by SAPK2/p38 and also by
MAPKAPK-2, one of the downstream targets of
SAPK2/p38, which might indicate that direct phos-
phorylation of the transporter is possible. The obser-
vation that phosphorylation of GLUT4 inactivates
the transporter [29,30] suggests, however, that phos-
phorylation is not a general mechanism for activat-
ing glucose transporters. Alternatively, it has been
proposed that cytosolic proteins associated with
GLUT1 located in the plasma membrane might act
as tonic inhibitors [31], and that conformational
changes in these proteins somehow unmask exofacial
sites at the transporter. The presently observed delay
of about 30 min between peak activation of SAPK2/
p38 and maximal e¡ect on glucose transport rate in
presence of anisomycin is of interest. This suggests
one or more rate-limiting steps downstream of
SAPK2/p38 activation and argues against a direct
phosphorylation of the transporter by the kinase.
In contrast to anisomycin the arsenite-induced glu-
cose transport was only partially suppressed by SB
203580, suggesting that SAPK2/p38 and at least one
additional signal transduction pathway must be in-
volved in the response to arsenite. The relatively rap-
id e¡ect of arsenite on glucose transport compared to
SAPK2/p38 activation, suggested that the early
changes in glucose transport in response to arsenite
might represent a SAPK2/p38-independent activa-
tion. The observation that glucose transport in re-
sponse to arsenite proved faster in onset compared
to that of anisomycin, provides further support for
the involvement of di¡erent signaling pathways and/
or mechanisms in the early arsenite and anisomycin
response. Several reports show that arsenite-induced
glucose uptake are related to an increased amount of
transporters in the plasma membrane, and it has
been suggested that this e¡ect may share some com-
mon features with insulin and also IGF-I-stimulated
translocation of transporters [32,33]. Although the
e¡ect of arsenite was quantitatively similar to that
of IGF-I, it was PI3-kinase independent. Thus, in
case of a shared mechanism, signaling pathways ac-
tivated by IGF-I and arsenite must necessarily con-
verge on a common substrate downstream of PI3-
kinase. However, p70S6 kinase, which is activated
by PI3-kinase and shown to be involved in insulin-
and stress-induced GLUT1 expression [28,34], did
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not appear to be coupled to either arsenite- or IGF-
I-stimulated glucose transport in chroma⁄n cells. A
role of AMP-activated protein kinase (AMPK) in
cellular responses to stress that causes ATP deple-
tion, such as treatment with arsenite, has been re-
ported [35]. Recently, AMPK activation has also
been observed to enhance glucose uptake in several
cell types [36,37]. Activation of this kinase may thus
be a plausible explanation for the SAPK2/p38-inde-
pendent glucose transport observed in arsenite
treated chroma⁄n cells.
It is noteworthy that both arsenite and anisomycin
augmented the e¡ect of IGF-I on glucose transport,
while the two stressors in combination failed to en-
hance the transport rate relative to that obtained by
arsenite alone. This clearly demonstrates that maxi-
mal transport rate was not achieved by either stimuli
by itself, consistent with IGF-I signaling being medi-
ated through a pathway distinct from that of arsenite
and anisomycin. The lack of total additive e¡ect be-
tween arsenite or anisomycin in combination with
IGF-I indicated, on the other hand, that there might
be a ceiling on the level of transport activity that can
be achieved by activation of di¡erent signal-trans-
duction pathways in parallel. This notion lends sup-
port from previous reports which suggest a satura-
tion point for the amount of fully functional
transporters accommodated at the cell surface [38].
It is also noteworthy that TNF-K did not enhance
glucose transport although SAPK2/p38 was phos-
phorylated, albeit more transiently and weaker than
in presence of anisomycin or arsenite, possibly indi-
cating that strong and sustained SAPK2/p38 activa-
tion is required for an e¡ect on glucose transport.
Alternatively, TNF-K signaling to SAPK2/p38 may
be assembled in a network di¡erent from that of
arsenite- and anisomycin-induced activation of
SAPK2/p38 that is restrained from coupling to glu-
cose transport activation.
In summary, the results show that the arsenite-
and anisomycin-induced glucose uptake in chromaf-
¢n cells di¡er with respect to time-dependent
changes, maximal e¡ects, and dependency on
SAPK2/p38 activation. This indicates that the e¡ects
of the two types of cellular stress are mediated by at
least two di¡erent signaling pathways which are dis-
tinct from that activated by IGF-I.
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